新冠疫情封锁对迪拜 2 型糖尿病患者血糖控制的影响。
Impact of COVID-19 Lockdown on Glycemic Control in Patients with Type 2 Diabetes Mellitus in Dubai.
机构信息
Health Centres Department, Primary Health Care Sector, Dubai Health Authority, Dubai, UAE.
Medical Research Section, Medical Education Department, Dubai Health Authority, Dubai, UAE.
出版信息
Curr Diabetes Rev. 2022;18(8):e081221198650. doi: 10.2174/1573399818666211208102729.
OBJECTIVE
The objective of this study is to evaluate the impact of the COVID-19 lockdown on glycemic control and accompanying laboratory parameters in patients with type 2 Diabetes Mellitus.
METHODS
This study is a retrospective cohort study that was done on a multicenter level. It was conducted during the lockdown in 341 individuals. HbA1c was tested to measure glycemic control immediately before and after the lockdown period that lasted for 13 weeks.
RESULTS
The primary outcome was the improvement of mean HbA1C after 13 weeks of lockdown compared to the pre-lockdown HbA1C. It was found that the mean HbA1C improved from 7.5±1.5 to 7.3±1.5 with a p-value of 0.001.
CONCLUSION
Our study showed that patients with type 2 diabetes mellitus exhibited an improvement in their glycemic control after the period of lockdown.
目的
本研究旨在评估 COVID-19 封锁对 2 型糖尿病患者血糖控制和伴随的实验室参数的影响。
方法
这是一项多中心回顾性队列研究，在封锁期间对 341 名个体进行了研究。封锁前和持续 13 周的封锁后立即检测糖化血红蛋白（HbA1c）以衡量血糖控制情况。
结果
主要结局是与封锁前的 HbA1c 相比，封锁 13 周后平均 HbA1c 的改善。结果发现，平均 HbA1c 从 7.5±1.5 改善至 7.3±1.5，p 值<0.001。
结论
我们的研究表明，2 型糖尿病患者在封锁期后血糖控制得到改善。
Zotero 插件